Antiplatelet Therapy and Spontaneous Retroperitoneal Hematoma: A Case Report and Literature Review

BACKGROUND Dual antiplatelet therapy has proven efficacy in primary and secondary prevention of coronary artery disease with a relatively good safety profile. Review of the literature revealed 8 cases of spontaneous retroperitoneal hematoma secondary to antiplatelet treatment. CASE REPORT We report...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of case reports 2017-01, Vol.18, p.85-89
Main Authors: Ibrahim, Walid, Mohamed, Abdelaziz, Sheikh, Muhammed, Shokr, Mohamed, Hassan, Abubaker, Wienberger, Jarrett, Afonso, Luis C
Format: Article
Language:English
Subjects:
Aged
Coronary Artery Disease - prevention & control
Hematoma - chemically induced
Hematoma - diagnosis
Humans
Male
Platelet Aggregation Inhibitors - adverse effects
Platelet Aggregation Inhibitors - therapeutic use
Retroperitoneal Space
Tomography, X-Ray Computed
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND Dual antiplatelet therapy has proven efficacy in primary and secondary prevention of coronary artery disease with a relatively good safety profile. Review of the literature revealed 8 cases of spontaneous retroperitoneal hematoma secondary to antiplatelet treatment. CASE REPORT We report the case of a 66-year-old male with a flare of acute gout secondary to uncontrolled chronic myeloid leukemia. The patient was started on dual antiplatelet treatment following a drug-eluted stent placement for symptomatic coronary artery disease. He suffered from an unexplained acute drop of five grams of hemoglobin from 10.4 to 5.8 g/dL and symptomatic anemia. The initial labs excluded occult GI bleeding, hemolysis, and bone marrow suppression. However, an abdominal CT scan showed an approximately 7.2×4.7×6.7 cm spontaneous retroperitoneal hematoma involving the left iliacus muscle. The patient was successfully treated conservatively by discontinuing antiplatelet therapy and supportive measures. CONCLUSIONS A spontaneous retroperitoneal hematoma often presents without localizing signs and symptoms and therefore should be considered in any case of unexplained blood loss in patients on antiplatelet therapy. CT without contrast is the modality of choice to diagnose retroperitoneal hematoma.
ISSN:1941-5923
1941-5923
DOI:10.12659/ajcr.901622